NFGH
Nan Fung Group Holdings Portfolio holdings
AUM
$63.4M
This Quarter Return
-3.96%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$312M
AUM Growth
+$312M
(-2.9%)
Cap. Flow
+$84.5M
Cap. Flow
% of AUM
27.06%
Top 10 Holdings %
Top 10 Hldgs %
89.79%
Holding
29
New
5
Increased
5
Reduced
1
Closed
1
Top Buys
| 1 |
Illumina
ILMN
|
$52.6M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$21M |
| 3 |
Rani Therapeutics
RANI
|
$8.8M |
| 4 |
Vir Biotechnology
VIR
|
$3.98M |
| 5 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$666K |
Top Sells
| 1 |
Ardelyx
ARDX
|
$2.47M |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$1.71M |
Sector Composition
| 1 | Healthcare | 67.1% |
| 2 | Financials | 30.02% |
| 3 | Communication Services | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Synlogic
SYBX
$17M
| $209K | 0.07% | 68,634 | – | – |
|
27
Dyne Therapeutics
DYN
$1.92B
| $189K | 0.06% | +11,629 | New | +$189K |
|
28
Akero Therapeutics
AKRO
$3.74B
| $78K | 0.03% | 3,470 | – | – |
|
|
29
Ardelyx
ARDX
$1.53B
| – | – | -325,233 | Closed | -$2.47M |
|